Research Diagnosis Related Groups (DRG) level mortality quality outcomes for Stanford Healthcare located at 300 Pasteur Dr, Stanford, CA, 94305 & includes data from NPIs 1265581086, 1871543215
Dexur analyzed Q2 2016 (April to June 2016) Medicare claims data to benchmark mortality rates for Stanford Healthcare compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
Total Hospitalizations (Apr 2016 to Jun 2016) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Apr 2016 to Jun 2016) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Apr 2016 to Jun 2016) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
All Inpatient | 2,383 | 2,272 | ||||||||||||||||||||||
Surgical | 1,220 | 1,180 | ||||||||||||||||||||||
Non Surgical | 1,163 | 1,092 | ||||||||||||||||||||||
Cardiovascular | 445 | 423 | ||||||||||||||||||||||
General Surgery | 411 | 388 | ||||||||||||||||||||||
Orthopedics | 303 | 298 | ||||||||||||||||||||||
General Medicine | 252 | 232 | ||||||||||||||||||||||
Gastroenterology & Endocrinology | 156 | 150 | ||||||||||||||||||||||
Oncology & Hematology | 142 | 127 | ||||||||||||||||||||||
Urology | 138 | 135 | ||||||||||||||||||||||
Pulmonology | 135 | 132 | ||||||||||||||||||||||
Neurology | 120 | 112 | ||||||||||||||||||||||
Spine | 117 | 116 | ||||||||||||||||||||||
Colorectal | 51 | 50 | ||||||||||||||||||||||
Psychiatry & Mental Disorders | 50 | 48 | ||||||||||||||||||||||
Obstetrics & Gynecology | 29 | 28 | ||||||||||||||||||||||
Obesity, Bariatric, Stomach & Duodenal | 26 | 25 |
Total Hospitalizations (Apr 2016 to Jun 2016) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Apr 2016 to Jun 2016) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Apr 2016 to Jun 2016) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Heart Failure And Shock | ||||||||||||||||||||||||
DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Endovascular Procedures | ||||||||||||||||||||||||
DRG 267: ENDOVASCULAR CARDIAC VALVE REPLACEMENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 266: ENDOVASCULAR CARDIAC VALVE REPLACEMENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Cardiac Valve And Other Major Cardiothoracic Procedures | ||||||||||||||||||||||||
DRG 220: CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITHOUT CARDIAC CATHETERIZATION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
DRG 219: CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITHOUT CARDIAC CATHETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Cardiac Arrhythmia And Conduction Disorders | ||||||||||||||||||||||||
DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
DRG 310: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Other Vascular Procedures | ||||||||||||||||||||||||
DRG 253: OTHER VASCULAR PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Permanent Cardiac Pacemaker Implant | ||||||||||||||||||||||||
DRG 243: PERMANENT CARDIAC PACEMAKER IMPLANT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||||||||||||||
DRG 286: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Other Circulatory System Diagnoses | ||||||||||||||||||||||||
DRG 314: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||||||||||||||
Acute Myocardial Infarction | ||||||||||||||||||||||||
Peripheral Vascular Disorders | ||||||||||||||||||||||||
Percutaneous Intracardiac Procedures | ||||||||||||||||||||||||
Syncope And Collapse | ||||||||||||||||||||||||
DRG 312: SYNCOPE AND COLLAPSE | ||||||||||||||||||||||||
Aortic And Heart Assist Procedures | ||||||||||||||||||||||||
DRG 269: AORTIC AND HEART ASSIST PROCEDURES EXCEPT PULSATION BALLOON W/O MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Apr 2016 to Jun 2016) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Apr 2016 to Jun 2016) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Apr 2016 to Jun 2016) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Craniotomy And Endovascular Intracranial Procedures | ||||||||||||||||||||||||
DRG 025: CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 026: CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
DRG 027: CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||||||||||||||
DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Pancreas, Liver And Shunt Procedures | ||||||||||||||||||||||||
DRG 406: PANCREAS, LIVER AND SHUNT PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Major Chest Procedures | ||||||||||||||||||||||||
DRG 164: MAJOR CHEST PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Craniotomy With Major Device Implant Or Acute Complex Cns Pdx | ||||||||||||||||||||||||
DRG 023: CRANIOTOMY WITH MAJOR DEVICE IMPLANT OR ACUTE COMPLEX CNS PDX WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) OR CHEMOTHERAPY IMPLANT | ||||||||||||||||||||||||
Other O.R. Procedures For Injuries | ||||||||||||||||||||||||
Wound Debridement And Skin Graft Except Hand, For Musculoskeletal And Connective Tissue Disorders | ||||||||||||||||||||||||
DRG 464: WOUND DEBRIDEMENT AND SKIN GRAFT EXCEPT HAND FOR MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Ecmo Or Tracheostomy With Mv >96 Hours Or Pdx Except Face, Mouth And Neck | ||||||||||||||||||||||||
DRG 003: ECMO OR TRACHEOSTOMY WITH MV >96 HOURS OR PDX EXCEPT FACE, MOUTH AND NECK WITH MAJOR O.R. PROCEDURE | ||||||||||||||||||||||||
Extensive O.R. Procedure Unrelated To Principal Diagnosis | ||||||||||||||||||||||||
DRG 981: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Extracranial Procedures | ||||||||||||||||||||||||
Peritoneal Adhesiolysis |
Total Hospitalizations (Apr 2016 to Jun 2016) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Apr 2016 to Jun 2016) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Apr 2016 to Jun 2016) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||||||||||||||
DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Major Joint And Limb Reattachment Procedures Of Upper Extremity | ||||||||||||||||||||||||
DRG 483: MAJOR JOINT/LIMB REATTACHMENT PROCEDURE OF UPPER EXTREMITIES | ||||||||||||||||||||||||
Revision Of Hip Or Knee Replacement | ||||||||||||||||||||||||
DRG 467: REVISION OF HIP OR KNEE REPLACEMENT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Hip And Femur Procedures Except Major Joint | ||||||||||||||||||||||||
DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Other Musculoskeletal System And Connective Tissue O.R. Procedures | ||||||||||||||||||||||||
DRG 517: OTHER MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE O.R. PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Lower Extremity And Humerus Procedures Except Hip,Foot,Femur |
Total Hospitalizations (Apr 2016 to Jun 2016) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Apr 2016 to Jun 2016) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Apr 2016 to Jun 2016) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Septicemia Or Severe Sepsis | ||||||||||||||||||||||||
DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||||||||||||||
DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Disorders Of Liver Except Malignancy, Cirrhosis And Alcoholic Hepatitis | ||||||||||||||||||||||||
Signs And Symptoms | ||||||||||||||||||||||||
DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Complications Of Treatment |
Total Hospitalizations (Apr 2016 to Jun 2016) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Apr 2016 to Jun 2016) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Apr 2016 to Jun 2016) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||||||||||||||
DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 391: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
G.I.Hemorrhage | ||||||||||||||||||||||||
DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
G.I. Obstruction | ||||||||||||||||||||||||
Other Digestive System Diagnoses | ||||||||||||||||||||||||
DRG 393: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Endocrine Disorders |
Total Hospitalizations (Apr 2016 to Jun 2016) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Apr 2016 to Jun 2016) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Apr 2016 to Jun 2016) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chemotherapy Without Acute Leukemia As Secondary Diagnosis | ||||||||||||||||||||||||
DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Nervous System Neoplasms | ||||||||||||||||||||||||
Lymphoma And Non-Acute Leukemia | ||||||||||||||||||||||||
Digestive Malignancy | ||||||||||||||||||||||||
Respiratory Neoplasms | ||||||||||||||||||||||||
Malignancy Of Hepatobiliary System Or Pancreas |
Total Hospitalizations (Apr 2016 to Jun 2016) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Apr 2016 to Jun 2016) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Apr 2016 to Jun 2016) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Renal Failure | ||||||||||||||||||||||||
DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Kidney And Ureter Procedures | ||||||||||||||||||||||||
Other Kidney And Urinary Tract Diagnoses | ||||||||||||||||||||||||
DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Major Bladder Procedures | ||||||||||||||||||||||||
DRG 654: MAJOR BLADDER PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Kidney And Urinary Tract Infections | ||||||||||||||||||||||||
DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Major Male Pelvic Procedures | ||||||||||||||||||||||||
Kidney Transplant | ||||||||||||||||||||||||
DRG 652: KIDNEY TRANSPLANT |
Total Hospitalizations (Apr 2016 to Jun 2016) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Apr 2016 to Jun 2016) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Apr 2016 to Jun 2016) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Simple Pneumonia And Pleurisy | ||||||||||||||||||||||||
DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Respiratory Infections And Inflammations | ||||||||||||||||||||||||
DRG 178: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Major Chest Trauma | ||||||||||||||||||||||||
Pulmonary Embolism |
Total Hospitalizations (Apr 2016 to Jun 2016) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Apr 2016 to Jun 2016) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Apr 2016 to Jun 2016) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||||||||||||||
DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Seizures | ||||||||||||||||||||||||
DRG 101: SEIZURES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Other Disorders Of Nervous System | ||||||||||||||||||||||||
Traumatic Stupor And Coma, Coma < 1 Hour |
Total Hospitalizations (Apr 2016 to Jun 2016) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Apr 2016 to Jun 2016) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Apr 2016 to Jun 2016) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Combined Anterior/Posterior Spinal Fusion | ||||||||||||||||||||||||
DRG 454: COMBINED ANTERIOR/POSTERIOR SPINAL FUSION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Spinal Fusion Except Cervical | ||||||||||||||||||||||||
DRG 460: SPINAL FUSION EXCEPT CERVICAL WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Back And Neck Procedures, Except Spinal Fusion, Or Disc Devices/Neurostimulators | ||||||||||||||||||||||||
DRG 520: BACK AND NECK PROCEDURES EXCEPT SPINAL FUSION WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Cervical Spinal Fusion | ||||||||||||||||||||||||
DRG 472: CERVICAL SPINAL FUSION WITH COMPLICATION OR COMORBIDITY (CC) |
Total Hospitalizations (Apr 2016 to Jun 2016) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Apr 2016 to Jun 2016) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Apr 2016 to Jun 2016) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Major Small And Large Bowel Procedures | ||||||||||||||||||||||||
DRG 330: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) |
Total Hospitalizations (Apr 2016 to Jun 2016) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Apr 2016 to Jun 2016) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Apr 2016 to Jun 2016) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Psychoses | ||||||||||||||||||||||||
DRG 885: PSYCHOSES |
Total Hospitalizations (Apr 2016 to Jun 2016) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Apr 2016 to Jun 2016) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Apr 2016 to Jun 2016) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Stomach, Esophageal And Duodenal Procedures | ||||||||||||||||||||||||
DRG 327: STOMACH, ESOPHAGEAL AND DUODENAL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) |